Bowel cancer screening less likely with low numeracy skills
the ONA take:
According to a new study published in the Journal of Health Psychology, those who have trouble understanding numbers may be less likely to undergo screening for bowel cancer, as well as being more likely to fear a negative result.
For the study, researchers asked people aged 45 to 59 to complete a questionnaire that evaluated their attitudes toward the bowel screening test and their numerical skills. For example, one question asked to identify whether 1 in 10, 1 in 100, or 1 in 1000 represents the greatest risk of developing a disease. About 46% of the 965 respondents got this question wrong.
Furthermore, respondents who were found to have lower numerical skills were more likely to believe that the test was disgusting or embarrassing, and more afraid of a negative result. These people also tended to understand less about the disease and were more likely ignore cancer information.
Specifically, respondents with low numerical skills were more likely to believe they did not need to be screened because they believed they were healthy and their physicians had not advised them to do so.
The findings of this study may help clinicians identify patients less likely to undergo a bowel cancer screening and to aid patients overcome barriers to prevent cancer or detect it early.
Those who have trouble understanding numbers may be less likely to undergo screening for bowel cancer.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|